PRKS:NYSEUnited Parks & Resorts Inc. Analysis
Data as of 2026-04-25 - not real-time
$33.80
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
United Parks & Resorts (PRKS) trades around $33.80, sitting just above its 20‑day SMA ($34.84) but well below the 200‑day SMA ($41.65), signaling a short‑term bounce within a longer‑term downtrend. Technical momentum is mixed: the RSI hovers near the neutral 45 mark, while the MACD histogram is negative and the signal line is flagged bearish, suggesting limited upside in the near term. The stock’s beta of 1.5 and 30‑day volatility of 43 % imply heightened price swings, and volume remains stable but below average, pointing to modest liquidity. Fundamentally, the company faces pressure – revenue fell 2.8% YoY, Q4 GAAP profit missed expectations, and a hefty debt load of over $2.35 B dwarfs its cash balance of roughly $100 M, resulting in a negative book value per share. Nonetheless, valuation metrics appear attractive: a trailing PE of 11×, a forward PE near 7.7×, and analyst price targets averaging $41–$42 suggest upside of roughly 20‑25 % from current levels. Recent material news, including a DOJ lawsuit over accessibility policies, adds a regulatory headwind, but the broader market sentiment is in “Extreme Greed” mode, which could buoy the stock if operational improvements materialize.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Q4 earnings miss and revenue decline
- Bearish MACD and proximity to support level
- Pending DOJ accessibility lawsuit
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Forward EPS guidance implying earnings acceleration
- Attractive forward PE and analyst upside estimates
- Extreme greed market sentiment supporting risk‑on buying
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential debt restructuring and cash‑flow improvement
- Long‑term valuation upside relative to peer leisure assets
- Sector recovery as discretionary spending rebounds
Key Metrics & Analysis
Financial Health
Revenue Growth-2.80%
Profit Margin10.13%
P/E Ratio11.0
ROA9.29%
P/B Ratio-4.0
Op. Cash Flow$380.1M
Free Cash Flow$79.4M
Technical Analysis
TrendNeutral
RSI45.4
Support$28.77
Resistance$38.10
MA 20$34.84
MA 50$33.95
MA 200$41.65
MACDBearish
VolumeStable
Fear & Greed Index88.02
Valuation
Target Price$42.40
Upside/Downside25.44%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.51
Volatility43.68%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.